Methods for treating cardiovascular disease using a soluble CTLA4 molecule
US7671022B2 · kind B2 · utility
5Cited by
25References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 14, 2007 |
| Grant date | Mar 2, 2010 |
| Priority date | — |
| Expiry date | May 29, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions and methods for treating cardiovascular system diseases by administering to a subject soluble CTLA4 molecules that block endogenous B7 molecules from binding their ligands.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.